Build diluted EPS and release the three ledgers

Diluted EPS is not a forecast of what management thinks will convert. It is a controlled counterfactual: apply the method required for each potential common-share instrument, then include only the effects that dilute the Topic 260 control number.

Inventory before calculating

For every option, warrant, convertible, participating security, contingently issuable share, and stock-or-cash contract, record quantity, dates outstanding, classification, exercise or conversion terms, average market price, numerator effects, contingencies, actual conversion or settlement dates, retrospective adjustments, and current guidance route.

An omitted instrument and an excluded antidilutive instrument are different. Keep both the complete inventory and the included set.

Apply the treasury-stock method visibly

For qualifying options and warrants:

assumed exercise proceeds
  = exercise cash
  + required unrecognized compensation or other assumed proceeds

assumed repurchased shares
  = assumed proceeds / average market price

incremental shares
  = shares assumed issued - shares assumed repurchased

Use a zero floor when proceeds would repurchase more than the assumed issue. Weight instruments for the portion of the period outstanding. Use average market price for the period, not closing price because it is easy to find. Certain awards require additional assumed-proceeds and participation analysis.

Apply the if-converted method to both sides

For convertible debt, add qualifying after-tax interest and other numerator effects that would have been avoided, then add conversion shares from the beginning of the period or issuance date. For convertible preferred stock, add back the qualifying preferred dividend or other numerator amount and add conversion shares.

ASU 2020-06 is in the current lane. For instruments within its scope, use the current if-converted requirements rather than an older cash-conversion treasury-stock shortcut. A contract's classification and settlement terms still require their own analysis.

Test contingencies without forecasting

For contingently issuable shares, apply the guidance's reporting-date hypothetical: if the end of the reporting period were the end of the contingency period, how many shares would be issuable under the supplied facts? Some conditions require different timing or averaging. Use the exact contract and current rule; do not include all maximum shares because the target seems likely.

Actual conversion, exercise, or contingency satisfaction changes the file. Use the potential-share method before the actual date and actual common shares afterward, avoiding overlap or a gap.

Order from most to least dilutive

For instruments with numerator effects, compute incremental EPS:

incremental EPS = incremental numerator / incremental shares

Rank from lowest incremental EPS to highest. Treasury-stock instruments often enter first because they usually have no numerator effect, but compute the order. Starting from basic, add each instrument and recompute the running EPS. Stop before an instrument that would increase EPS or reduce loss per share.

Income from continuing operations available to common is the control number. Once the included set is determined, use that set consistently for discontinued operations and net income even when an individual downstream per-share amount appears antidilutive.

Treat loss periods and pending guidance carefully

Under current guidance, potential common shares are generally antidilutive when continuing operations is a loss. ASU 2025-12 adds a narrow pending exception analysis for specified stock-or-cash contracts reported as assets or liabilities: the combined numerator and denominator effect can dilute a loss. It is effective for annual periods beginning after December 15, 2026, unless early adopted. Keep the current result and pending adopted-result preview in separate columns.

Do not round instrument effects before ordering. A one-cent display can hide a full-precision reversal in dilution.

Reconcile basic to diluted

The EPS note should show:

List excluded antidilutive securities and why they were excluded. Tie face amounts, comparative recasting, and subsequent-event disclosure.

Release the three-ledger close

The final review moves in both directions:

• ending issued, treasury, and outstanding shares tie equity and the share note;
• actual dated share movements tie weighted common shares;
• preferred and participating rights tie distributions and the numerator;
• Topic 718 cost and tax tie earnings, equity or liabilities, and award notes;
• options, units, convertibles, and contingencies tie the potential-share inventory;
• dilution order and exclusions tie the EPS reconciliation; and
• current and pending standards lanes tie the entity's adoption facts.

A lower diluted EPS is not proof. Release follows from a complete inventory, correct methods, full-precision antidilution, and agreement among instruments, shares, dollars, dates, statements, and disclosures.